Compared with the III + IV stage, the FOXQ1 expression level in the I + II stage was higher in bladder urothelial carcinoma and skin cutaneous melanoma and lower in rectum adenocarcinoma, thyroid carcinoma, and testicular germ cell tumors (Figure 6B). Here, FOXQ1 is linked to thyroid gland carcinoma.